TRB Wealth Management LLC Buys Shares of 2,186 CME Group Inc. $CME

TRB Wealth Management LLC bought a new stake in shares of CME Group Inc. (NASDAQ:CME) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,186 shares of the financial services provider’s stock, valued at approximately $483,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Northwestern Mutual Investment Management Company LLC increased its position in shares of CME Group by 0.3% during the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after purchasing an additional 37 shares in the last quarter. Rehmann Capital Advisory Group raised its stake in CME Group by 4.3% in the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after purchasing an additional 37 shares during the last quarter. Endowment Wealth Management Inc. lifted its holdings in CME Group by 4.4% in the 4th quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after purchasing an additional 38 shares in the last quarter. NBT Bank N A NY lifted its holdings in CME Group by 2.3% in the 1st quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock valued at $492,000 after purchasing an additional 38 shares in the last quarter. Finally, Resonant Capital Advisors LLC boosted its stake in CME Group by 3.8% during the 1st quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock worth $317,000 after purchasing an additional 39 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

CME Group stock opened at $274.98 on Friday. The firm has a 50 day simple moving average of $251.17 and a 200-day simple moving average of $279.65. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market cap of $98.88 billion, a price-to-earnings ratio of 23.32, a price-to-earnings-growth ratio of 3.16 and a beta of 0.23.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating the consensus estimate of $2.91 by $0.08. The firm had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business’s revenue for the quarter was up .8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.96 EPS. On average, analysts expect that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a dividend of $1.30 per share. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio (DPR) is 44.11%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. TD Cowen dropped their target price on shares of CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Weiss Ratings downgraded shares of CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $316.00 to $323.00 in a research report on Thursday, June 11th. Barclays dropped their price objective on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research note on Thursday, July 9th. Finally, Morgan Stanley increased their price objective on shares of CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a report on Thursday, July 23rd. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $288.56.

Insider Transactions at CME Group

In other CME Group news, Director William R. Shepard bought 325 shares of CME Group stock in a transaction on Thursday, June 25th. The shares were bought at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the transaction, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.30% of the stock is currently owned by company insiders.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.